The investment seeks long-term capital growth; income is a secondary objective... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeValue
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| KCEIX | 12.56 | 0.06 | +0.48% |
| Knights of Columbus Long/Short Eq I | |||
| AEUDX | 9.07 | 0.04 | +0.44% |
| American Century Equity Income R6 | |||
| LEAIX | 15.92 | 0.04 | +0.25% |
| Lazard Emerging Markets Eq Advtg Instl | |||
| FBTCX | 28.38 | N/A | N/A |
| Fidelity Advisor Biotechnology C | |||
| ALCBX | 13.41 | N/A | N/A |
| ALPS/Smith Balanced Opportunity C | |||
A.I.dvisor indicates that over the last year, ALPAX has been closely correlated with VIVAX. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALPAX jumps, then VIVAX could also see price increases.
| Ticker / NAME | Correlation To ALPAX | 1D Price Change % | ||
|---|---|---|---|---|
| ALPAX | 100% | +0.53% | ||
| VIVAX - ALPAX | 85% Closely correlated | +0.53% | ||
| VIVIX - ALPAX | 85% Closely correlated | +0.53% | ||
| VVIAX - ALPAX | 85% Closely correlated | +0.52% | ||
| FFFMX - ALPAX | 81% Closely correlated | +0.22% | ||
| RMFEX - ALPAX | 80% Closely correlated | +0.22% | ||
More | ||||